0001892688-22-000023.txt : 20220214
0001892688-22-000023.hdr.sgml : 20220214
20220214163724
ACCESSION NUMBER: 0001892688-22-000023
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220214
DATE AS OF CHANGE: 20220214
EFFECTIVENESS DATE: 20220214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lynx1 Capital Management LP
CENTRAL INDEX KEY: 0001910456
IRS NUMBER: 851134656
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-22151
FILM NUMBER: 22633286
BUSINESS ADDRESS:
STREET 1: 2 RIDGE TOP DRIVE
CITY: HUMACAO
STATE: PR
ZIP: 00791
BUSINESS PHONE: 703-963-7214
MAIL ADDRESS:
STREET 1: 2 RIDGE TOP DRIVE
CITY: HUMACAO
STATE: PR
ZIP: 00791
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001910456
XXXXXXXX
12-31-2021
12-31-2021
Lynx1 Capital Management LP
2 RIDGE TOP DRIVE
HUMACAO
PR
00791
13F HOLDINGS REPORT
028-22151
N
Weston Nichols
Chief Investment Officer
703-963-7214
Weston Nichols
Humacao
PR
02-14-2022
1
10
114610
false
1
0001910444
Lynx1 Capital Advisors LLC
INFORMATION TABLE
2
lynx113fdec2021.xml
ALPINE IMMUNE SCIENCES INC
COM
02083G100
17478
1261927
SH
OTR
1
0
1261927
0
BELLUS HEALTH INC NEW
COM NEW
07987C204
16125
2003114
SH
OTR
1
0
2003114
0
CYMABAY THERAPEUTICS INC
COM
23257D103
4140
1224968
SH
OTR
1
0
1224968
0
IMMUNOGEN INC
COM
45253H101
15801
2129531
SH
OTR
1
0
2129531
0
MERUS N V
COM
N5749R100
24912
783398
SH
OTR
1
0
783398
0
OTONOMY INC
COM
68906L105
62
30000
SH
OTR
1
0
30000
0
PARDES BIOSCIENCES INC
COM
69945Q105
6574
401593
SH
OTR
1
0
401593
0
PIERIS PHARMACEUTICALS INC
COM
720795103
1449
383266
SH
OTR
1
0
383266
0
THESEUS PHARMACEUTICALS INC
COM
88369M101
5191
409358
SH
OTR
1
0
409358
0
TRAVERE THERAPEUTICS INC
COM
89422G107
22878
737061
SH
OTR
1
0
737061
0